- Home
- LPTX vs QIPT Comparison
LPTX vs QIPT Comparison
Compare LPTX & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- QIPT
- Stock Information
- Founded
- LPTX 2011
- QIPT 1993
- Country
- LPTX United States
- QIPT United States
- Employees
- LPTX N/A
- QIPT N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- QIPT
- Sector
- LPTX Health Care
- QIPT
- Exchange
- LPTX Nasdaq
- QIPT Nasdaq
- Market Cap
- LPTX 119.6M
- QIPT 112.0M
- IPO Year
- LPTX N/A
- QIPT N/A
- Fundamental
- Price
- LPTX $0.34
- QIPT $2.25
- Analyst Decision
- LPTX Buy
- QIPT Strong Buy
- Analyst Count
- LPTX 2
- QIPT 2
- Target Price
- LPTX $8.00
- QIPT $6.50
- AVG Volume (30 Days)
- LPTX 5.9M
- QIPT 125.2K
- Earning Date
- LPTX 03-26-2025
- QIPT 05-14-2025
- Dividend Yield
- LPTX N/A
- QIPT N/A
- EPS Growth
- LPTX N/A
- QIPT N/A
- EPS
- LPTX N/A
- QIPT N/A
- Revenue
- LPTX N/A
- QIPT $244,723,000.00
- Revenue This Year
- LPTX N/A
- QIPT $3.35
- Revenue Next Year
- LPTX N/A
- QIPT $5.39
- P/E Ratio
- LPTX N/A
- QIPT N/A
- Revenue Growth
- LPTX N/A
- QIPT 3.82
- 52 Week Low
- LPTX $0.28
- QIPT $2.22
- 52 Week High
- LPTX $4.79
- QIPT $4.23
- Technical
- Relative Strength Index (RSI)
- LPTX 33.17
- QIPT 36.51
- Support Level
- LPTX $0.28
- QIPT $2.22
- Resistance Level
- LPTX $0.65
- QIPT $2.42
- Average True Range (ATR)
- LPTX 0.05
- QIPT 0.10
- MACD
- LPTX 0.02
- QIPT 0.01
- Stochastic Oscillator
- LPTX 16.22
- QIPT 15.00
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About QIPT Quipt Home Medical Corp.
Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.